EMEA-001856-PIP02-16-M02

Table of contents

Key facts

Invented name
Alpivab
Active substance
Peramivir
Therapeutic area
Infectious diseases
Decision number
P/0257/2021
PIP number
EMEA-001856-PIP02-16-M02
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of influenza
Route(s) of administration
Intravenous use
Contact for public enquiries
BioCryst Ireland Limited

Tel. +1 9194505809
E-mail: pip.enquiries@biocryst.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating